Talk to us

A unique opportunity to study blood-drug interactions in real time

We offer in-house services to address important questions related to the safety and function of biopharmaceuticals.

Our services

With vast expertise in immunology and preclinical drug development, we assure high-quality immune assessments. All our services are based on Immuneed’s specially developed platform.

How it works

The unique platform provides a physiologically relevant testing environment that closely mimics the blood system within the human body. It provides multiple readouts from fresh, circulating human blood – making it a powerful preclinical testing method.

With Immuneed’s “Blood Loop”, a single platform gives us multiple readouts which provide us with a solid understanding of cytokines, complement and drug biodistribution.

- Prinicpal Scientist at Bioarctic Neuroscience

Immuneed is a highly appreciated partner and have very short and flexible lead times, usually around 5 weeks. Adding the high sensitivity and reproducibility of the loop in assessing cytokine release and cell activation, we have chosen to use it as a routine in our preclinical development.

- Director of Translational Medicine at Affibody

Selected customers

Knowledge center

Knowledge is the path to possibility.

As researchers we’re passionate about knowledge, and we strive daily to increase it for our clients and ourselves. In addition, we welcome the opportunity to share it. Here are opportunities to explore what we know, both in publication and in person.

A look back and a look forward

3/2, 2021
For better or worse, 2020 was a year like no other. Nonetheless, there were a good deal of positive developments at Immuneed. Those pave the way for an exciting 2021, which promises – among other things – an expanding offering to Immuneed customers. Immuneed CEO Camilla Oldgren sums up the past months and gives an idea of what’s to come.

Blog

Here you'll find ideas for improving your preclinical testing. We share our best tips and tricks on preclinical drug development with a particular focus on immunology and safety.

To blog